MedPath

Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectomy Surgery and Controls

Completed
Conditions
Nuclear Sclerotic Cataract
Registration Number
NCT00406263
Lead Sponsor
Barnes Retina Institute
Brief Summary

Progression of nuclear sclerotic cataract after pars plana vitrectomy has been recognized for many years The mechanism for the rapid progression of nuclear sclerotic cataract remains unclear. The objective of this trial is to evaluate and compare the level and progression of cataract advancement in controls versus eyes that have undergone 20-gauge pars plana vitrectomy and 25-gauge pars plana vitrectomy.

Detailed Description

Approximately 105 patients will be recruited to obtain 35 control eyes that have not had pars plana vitrectomy and 35 eyes who will have undergone 20-gauge pars plana vitrectomy and 35 eyes will have undergone 25-gauge pars plana vitrectomy. Scheimpflug crystalline lens photographs will be taken for evaluation of level and progression of cataract development.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • phakic eyes of patients that are scheduled to undergo pars plana vitrectomy,
  • controls will be phakic eyes of patients that have not undergone andy kind of intraocular surgery,
  • age 18 and older
Read More
Exclusion Criteria
  • any eye that is pseudophakic,
  • has had previous vitreoretinal surgery,
  • has had previous intravitreal injection,
  • previous intraocular inflammatory condition such as uveitis,
  • previous irradiation,
  • any patient with a history of ocular malignancy,
  • history of infectious intraocular condition
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Barnes Retina Institute

🇺🇸

St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath